Process for the production of carnitine from β-lactones

US9394238B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9394238-B2
Application numberUS-201414521700-A
CountryUS
Kind codeB2
Filing dateOct 23, 2014
Priority dateJul 21, 2010
Publication dateJul 19, 2016
Grant dateJul 19, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a method for the production of L-carnitine, wherein a β-lactone, which is a 4-(halomethyl)oxetane-2-one, is converted into carnitine with trimethylamine (TMA), wherein the β-lactone is not subjected to a basic hydrolysis step before being contacted with the trimethylamine. The invention also relates to a carnitine having a unique impurity profile.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for the production of L-carnitine, wherein a β-lactone, which is a 4-(halomethyl)oxetane-2-one, is converted into carnitine with trimethylamine (TMA), wherein the β-lactone is not subjected to a hydrolysis step before being contacted with the trimethylamine. 2. The process of claim 1 , wherein a basic hydrolysis and addition of trimethylamine (TMA) are carried out in one process step. 3. The process of claim 1 , wherein the basic hydrolysis is carried out with a metal hydroxide, preferably sodium hydroxide. 4. The process of claim 3 , wherein the β-lactone is brought into contact with the metal hydroxide and the trimethylamine essentially at the same time. 5. The process of claim 3 , wherein the amount of the metal hydroxide is 1.1 to 1.6 equivalents, preferably 1.2 to 1.4 equivalents, based on the initial amount of β-lactone. 6. The process of claim 3 , wherein the β-lactone is brought into contact with an aqueous solution comprising the metal hydroxide and the trimethylamine. 7. The process of claim 3 , wherein a solution of the β-lactone in an organic solvent is provided and mixed with an aqueous solution comprising TMA and a metal hydroxide. 8. The process of claim 1 , wherein the reaction is carried out at a temperature between −20° C. and 40° C., preferably between 0° C. and 25° C. 9. The process of claim 1 , wherein basic hydrolysis is mediated by the TMA and no additional base is added for basic hydrolysis. 10. The process of claim 1 , wherein the β-lactone is a chiral β-lactone and the carnitine is L-carnitine. 11. The process of claim 1 , comprising an additional step, in which the L-carnitine is purified via a combination of electrodialysis and subsequent recrystallization. 12. The process of claim 1 , comprising a preceding step, in which the β-lactone is obtained in a [2+2] cycloaddition of ketene with an aldehyde X—CH 2 —CHO, wherein X is selected from Cl, Br and I, in the presence of a chiral catalyst. 13. The process of claim 12 , wherein the chiral catalyst is a Lewis acid-Lewis base bifunctional metal catalyst or an organic phosphine catalyst. 14. L-carnitine, characterized by having an amount of hydroxycrotonic acid in the range of 0.5-0.1 wt-% or in the range of 0.5-0.005 wt-%. 15. The process of claim 4 , wherein the amount of the metal hydroxide is 1.1 to 1.6 equivalents, preferably 1.2 to 1.4 equivalents, based on the initial amount of β-lactone. 16. The process of claim 4 , wherein the β-lactone is brought into contact with an aqueous solution comprising the metal hydroxide and the trimethylamine. 17. The process of claim 5 , wherein the β-lactone is brought into contact with an aqueous solution comprising the metal hydroxide and the trimethylamine. 18. The process of claim 6 , wherein a solution of the β-lactone in an organic solvent is provided and mixed with an aqueous solution comprising TMA and a metal hydroxide. 19. The L-carnitine of claim 14 , obtainable by a process according to claim 11 .

Assignees

Inventors

Classifications

  • C07C229/22Primary

    the carbon skeleton being further substituted by oxygen atoms · CPC title

  • Separation; Purification · CPC title

  • Beta-lactones · CPC title

  • Crystallisation · CPC title

  • by reaction of ammonia or amines with acids containing functional groups · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9394238B2 cover?
The invention relates to a method for the production of L-carnitine, wherein a β-lactone, which is a 4-(halomethyl)oxetane-2-one, is converted into carnitine with trimethylamine (TMA), wherein the β-lactone is not subjected to a basic hydrolysis step before being contacted with the trimethylamine. The invention also relates to a carnitine having a unique impurity profile.
Who is the assignee on this patent?
Lonza Ag
What technology area does this patent fall under?
Primary CPC classification C07C229/22. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jul 19 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).